{4-[5-(4,4-dimethyl-cyclohexa-1,5-dienyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-thiazol-2-yl}-(4-methyl-piperazin-1-yl)-methanone | 1046791-32-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: {4-[5-(4,4-dimethyl-cyclohexa-1,5-dienyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-thiazol-2-yl}-(4-methyl-piperazin-1-yl)-methanone
• 英文别名: [4-[5-(4,4-dimethylcyclohexa-1,5-dien-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazol-2-yl]-(4-methylpiperazin-1-yl)methanone
• CAS: 1046791-32-5
• 化学式: C₂₄H₂₇N₅OS
• 分子量: 433.577
• InChiKey: GHHUMVQJRUXCQT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  31
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  93.4
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE
  申请人：GRACZYK Piotr Pawel

  公开号：US20100069358A1

  公开（公告）日：2010-03-18

  The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them.

  本发明提供了一种化合物(I)或其药学上可接受的盐，用于抑制c-Jun N末端激酶（JNK）活性，特别是用于治疗神经退行性疾病、炎症性疾病和/或自身免疫性疾病。本发明还提供了制备该化合物(I)或其药学上可接受的盐的方法和含有它们的组合物。
• THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE
  申请人：Eisai R&D Management Co., Ltd.

  公开号：EP2125801A1

  公开（公告）日：2009-12-02
• US7951802B2
  申请人：——

  公开号：US7951802B2

  公开（公告）日：2011-05-31
• [EN] THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE<br/>[FR] UTILISATION DE 7-AZAINDOLES DANS L'INHIBITION DE C-JUN N-TERMINAL KINASE
  申请人：EISAI LONDON RES LAB LTD

  公开号：WO2008095943A1

  公开（公告）日：2008-08-14

  [EN] The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them.
  [FR] La présente invention porte sur un composé de formule (I) ; ou sur un sel pharmaceutiquement acceptable de celui-ci dans l'inhibition de l'activité C-Jun N-terminal kinase (JNK) et, en particulier, dans le traitement de troubles neuro-dégénératifs, de maladies inflammatoires et/ou de maladies auto-immunes. L'invention propose également des procédés pour la fabrication desdits composés de formule (I) ou sur un sel pharmaceutiquement acceptable de celui-ci, et sur des compositions les contenant.